| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/000992289603501101
Neurofibromatosis Type 1An Update and Review for the Primary PediatricianMedical Genetics Birth Defects Center, Steven Spielberg Pediatric Research Center, Ahmanson Pediatric Center, SHARE's Child Disability Center, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048; Hadassah Medical School, Jerusalem, Israel
Medical Genetics Birth Defects Center, Steven Spielberg Pediatric Research Center, Ahmanson Pediatric Center, SHARE's Child Disability Center, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048
The Neurofibromatosis Institute, 5415 Briggs Avenue, La Crescenta, CA 91214
Medical Genetics Birth Defects Center, Steven Spielberg Pediatric Research Center, Ahmanson Pediatric Center, SHARE's Child Disability Center, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA 90048 With an incidence of 1 in 3,000, neurofibromatosis type 1 (NFl), or von Recklinghausen disease, is one of the most common genetic disorders encountered by primary care physicians. NFI is a multisystem disease that affects more than one million people worldwide (more than 80,000 in the United States). Although most pediatricians have patients with NFl in their practices, many affected individuals go undiagnosed as children. This article is intended to facilitate the diagnosis and management of young patients with NFl.
This article has been cited by other articles:
|
|||||||||||||
